Showing results (1931-1940 of 2,046) with videos related to

Sort By:
Pageof 205
JAMA Cardiology|May 16, 2021
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH TrialSteven E Nissen, A Michael Lincoff, Kathy Wolski, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Cancer Research|July 31, 2025
Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell ImmunotherapyPaola Manara, Austin D Newsam, Venu Venkatarame Gowda Saralamma, et al.
Cell|August 30, 2016
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell ActivationDonnele Daley, Constantinos Pantelis Zambirinis, Lena Seifert, et al.
European Heart Journal Open|August 4, 2022
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammationPaul C Cremer, Calvin C Sheng, Debasis Sahoo, et al.
Gut|August 9, 2024
Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease familiesJonathan P Jacobs, Elizabeth A Spencer, Drew S Helmus, et al.
Biomedical Chromatography : BMC|June 18, 2017
LC-MS/MS characterization, anti-inflammatory effects and antioxidant activities of polyphenols from different tissues of Korean Petasites japonicus (Meowi)Jin Young Choi, Kebede Taye Desta, Venu Venkatarame Gowda Saralamma, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Critical Care Medicine|April 16, 2021
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network RegistryPatrick R Lawler, David D Berg, Jeong-Gun Park, et al.
Cancer|February 6, 2020
A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbesSaroj K Basak, Alakesh Bera, Alexander J Yoon, et al.
Pageof 205